Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA Comment on "Ethics...
Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA Comment on "Ethics in HTA: Examining the 'Need for Expansion'"
About this item
Full title
Author / Creator
Publisher
Iran: Kerman University of Medical Sciences
Journal title
Language
English
Formats
Publication information
Publisher
Iran: Kerman University of Medical Sciences
Subjects
More information
Scope and Contents
Contents
Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA).
Alternative Titles
Full title
Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA Comment on "Ethics in HTA: Examining the 'Need for Expansion'"
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_99b9e38a6cb14b378568faea90a285e8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_99b9e38a6cb14b378568faea90a285e8
Other Identifiers
ISSN
2322-5939
E-ISSN
2322-5939
DOI
10.15171/ijhpm.2019.73